UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients
Findings A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery…